Vanguard Group Inc Immunovant, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Immunovant, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 6,658,800 shares of IMVT stock, worth $183 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,658,800

Previous 6,509,753 2.29%

Holding current value

$183 Million

Previous $172 Million 6.59%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$27.51 - $27.51 $4.1 Million - $4.1 Million	149,047 Added 2.29%	6,658,800 $183 Million
Q2 2024 Aug 13, 2024	BUY	$25.1 - $31.61 $789,369 - $994,102	31,449 Added 0.49%	6,509,753 $172 Million
Q1 2024 May 10, 2024	BUY	$30.27 - $43.79 $19.7 Million - $28.5 Million	650,506 Added 11.16%	6,478,304 $209 Million
Q4 2023 Feb 14, 2024	SELL	$31.31 - $44.19 $12.7 Million - $17.9 Million	-405,348 Reduced 6.5%	5,827,798 $246 Million
Q3 2023 Nov 14, 2023	BUY	$18.55 - $39.96 $14.2 Million - $30.6 Million	764,530 Added 13.98%	6,233,146 $239 Million
Q2 2023 Aug 14, 2023	BUY	$14.2 - $23.75 $4.61 Million - $7.72 Million	324,907 Added 6.32%	5,468,616 $104 Million
Q1 2023 May 15, 2023	BUY	$15.27 - $19.72 $1.14 Million - $1.47 Million	74,590 Added 1.47%	5,143,709 $79.8 Million
Q4 2022 Feb 10, 2023	BUY	$6.59 - $17.75 $7.04 Million - $19 Million	1,068,669 Added 26.71%	5,069,119 $90 Million
Q3 2022 Nov 14, 2022	BUY	$3.93 - $6.37 $3,761 - $6,096	957 Added 0.02%	4,000,450 $22.3 Million
Q2 2022 Aug 12, 2022	BUY	$3.38 - $5.65 $790,176 - $1.32 Million	233,780 Added 6.21%	3,999,493 $15.6 Million
Q1 2022 May 13, 2022	SELL	$5.06 - $8.77 $346,134 - $599,920	-68,406 Reduced 1.78%	3,765,713 $20.8 Million
Q4 2021 Feb 14, 2022	BUY	$7.33 - $9.32 $621,825 - $790,643	84,833 Added 2.26%	3,834,119 $32.7 Million
Q3 2021 Nov 12, 2021	SELL	$7.01 - $11.37 $1.76 Million - $2.86 Million	-251,411 Reduced 6.28%	3,749,286 $32.6 Million
Q2 2021 Aug 13, 2021	BUY	$9.4 - $16.85 $37.6 Million - $67.4 Million	4,000,697 New	4,000,697 $42.3 Million

Others Institutions Holding IMVT

# of Institutions

211

Shares Held

66.9M

Call Options Held

2.3M

Put Options Held

631K

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Immunovant, Inc. Transaction History